Consistent with prior analysis [32, 33], our genomic profiling of the SK-UT-1 uterine leiomyosarcoma cell line confirmed mutations in TP53, RB1, APC and PTEN, but also the tumour suppressors TSC1 and TSC2. This evidence concerns the gene TSC2 and neoplasm.